Irinotecan-based combinations for the adjuvant treatment of stage III colon cancer

ONCOLOGY

Volumn 14, Issue 12 SUPPL. 14, 2000, Pages 47-50

  Saltz, Leonard ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DRUG DERIVATIVE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN;

ADJUVANT CHEMOTHERAPY; CLINICAL TRIAL; COLORECTAL TUMOR; CONTROLLED CLINICAL TRIAL; HUMAN; METASTASIS; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SURVIVAL; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS, PHASE II; CLINICAL TRIALS, PHASE III; COLORECTAL NEOPLASMS; FLUOROURACIL; HUMANS; LEUCOVORIN; NEOPLASM METASTASIS; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0034564145     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Willett CG, Tepper JE, Cohen AM: Failure patterns following curative resection of colonic carcinoma. Ann Surg 200:685-690, 1984.
2. Dwight RW, Humphrey EW, Higgins GA, et al: FUDR as an adjuvant to surgery in cancer of the large bowel. J Surg Oncol 5:243-250, 1973.
3. Higgins GA, Humphrey EW, Juler GL, et al: Adjuvant chemotherapy in the surgical treatment of large bowel cancer. Cancer 38:1461, 1976.
4. Gastrointestinal Tumor Study Group: Adjuvant therapy of colon cancer: Results of a prospectively randomized trial. N Engl J Med 310:737-742, 1984.
5. Buyse M, Zeleniuch-Jacquotte A, Chalmers TC: Adjuvant therapy of colorectal cancer: Why we still don't know. JAMA 259:3571-3578, 1988.
6. Laurie JA, Moertel CG, Fleming TR, et al: Surgical adjuvant therapy of large-bowel carci-noma: An evaluation of levamisole and the combination of levamisole and fluorouracil. J Clin Oncol, 7:1447-1456, 1989.
7. Moertel CG, Fleming TR, Macdonald JS, et al: Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: A final report. Ann Intern Med 122:321-326, 1995.
8. Haller DG, Catalano PJ, MacDonald JS, et al: Fluorouracil (FU), leucovorin (LV), and levamisole (LEV) adjuvant therapy for colon cancer: Five-year final report of INT-0089. Proc Am Soc Clin Oncol 17:256a, 1998.
9. Conti JA, Kemeny NE, Saltz LB, et al: Irinotecan is an active agent in untreated patients with metastatic colorectal cancer. J Clin Oncol 14:709-715, 1996.
10. Pilot HC, Wender MJ, O'Connell, et al: A phase II trial of CPT-11 (irinotecan) in patients with metastatic colorectal carcinoma: A North Central Cancer Treatment Group (NCCTG) Study. Proc Am Soc Clin Oncol 13:573a, 1994.
11. Rothenberg ML, Eckardt JR, Kuhn JG, et al: Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer. J Clin Oncol 14:1128-35, 1996.
12. Von Hoff DD, Rothenberg ML, Pilot HC, et al: Irinotecan (CPT-11) therapy for patients with previously treated metastatic colorectal cancer. Overall results of PDA-reviewed pivotal US clinical trials. Proc Am Soc Clin Oncol 16:803a, 1997.